Northern Trust
TNGX icon

Northern Trust’s Tango Therapeutics TNGX Stock Holding History

Northern Trust’s Portfolio TNGX Stock Details TNGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$18.1M Buy
862,940
+59,741
+7% +$832K ﹤0.01% 1739
2025
Q4 		$7.12M Buy
803,199
+197,638
+33% +$1.7M ﹤0.01% 2267
2025
Q3 		$5.09M Buy
605,561
+5,053
+0.8% +$34.2K ﹤0.01% 2494
2025
Q2 		$3.07M Buy
600,508
+151,126
+34% +$374K ﹤0.01% 2754
2025
Q1 		$616K Sell
449,382
-63,697
-12% -$156K ﹤0.01% 3490
2024
Q4 		$1.59M Buy
513,079
+33,829
+7% +$157K ﹤0.01% 3150
2024
Q3 		$3.69M Buy
479,250
+87,674
+22% +$837K ﹤0.01% 2648
2024
Q2 		$3.36M Sell
391,576
-9,553
-2% -$73.8K ﹤0.01% 2617
2024
Q1 		$3.18M Sell
401,129
-11,275
-3% -$121K ﹤0.01% 2740
2023
Q4 		$4.08M Buy
412,404
+10,963
+3% +$95.2K ﹤0.01% 2621
2023
Q3 		$4.52M Buy
401,441
+14,945
+4% +$91.1K ﹤0.01% 2510
2023
Q2 		$1.28M Sell
386,496
-11,998
-3% -$43.2K ﹤0.01% 3251
2023
Q1 		$1.57M Sell
398,494
-10,239
-3% -$59.4K ﹤0.01% 3043
2022
Q4 		$2.96M Sell
408,733
-8,037
-2% -$56.5K ﹤0.01% 2784
2022
Q3 		$1.51M Sell
416,770
-18,804
-4% -$80.3K ﹤0.01% 3151
2022
Q2 		$1.97M Buy
435,574
+314,019
+258% +$1.9M ﹤0.01% 3076
2022
Q1 		$921K Sell
121,555
-3,005
-2% -$26K ﹤0.01% 3455
2021
Q4 		$1.36M Buy
124,560
+11,410
+10% +$137K ﹤0.01% 3412
2021
Q3 		$1.46M Buy
+113,150
New +$1.36M ﹤0.01% 3415

Other funds holding TNGX

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $762M AUM 1,125.36% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
TGI
TRV GP IV Boston, Massachusetts $267M AUM 965.83% 1-Year Est. Return

Northern Trust's TNGX Position: Q1 2026 in Review

Northern Trust increased its Tango Therapeutics (TNGX) stake by 7.4% in Q1 2026, buying an estimated $832K and bringing the position to 862,940 shares worth $18.1M. The position accounts for ﹤0.01% of the portfolio, ranked #1739.

Northern Trust first reported a position in TNGX in Q3 2021 and has held it in 19 quarters since. 194 funds tracked by Wall St. Rank hold TNGX as of Q1 2026.

  • Northern Trust held 862,940 shares of Tango Therapeutics worth $18.1M as of Q1 2026.
  • Northern Trust bought 59,741 Tango Therapeutics shares in Q1 2026, an estimated $832K.
  • Tango Therapeutics made up ﹤0.01% of Northern Trust's portfolio in Q1 2026, its #1739 holding.
  • Northern Trust first reported a position in Tango Therapeutics in Q3 2021 and has held it in 19 quarters since.
  • 194 funds tracked by Wall St. Rank held Tango Therapeutics as of Q1 2026.

Based on Northern Trust's 13F filing for Q1 2026, filed 14 May 2026.